Literature DB >> 20051908

The diagnosis and surgical management of juxtaglomerular cell tumor of the kidney.

Dexin Dong1, Hanzhong Li, Weigang Yan, Weifeng Xu, Lin Lu, Zhengpei Zeng.   

Abstract

Juxtaglomerular cell tumor (JCT) of the kidney is a rare benign renal neoplasm. Four cases of JCT of the kidney have been diagnosed and treated surgically in our hospital from January 2005 to August 2008. The clinical features, laboratory examination, imaging examination, pathological results and electron microscopy examination were analyzed, and a review of the literature was summarized. Three patients underwent open partial nephrectomy, and one patient underwent laparoscopic partial nephrectomy. Pathological examination confirmed the final diagnosis of JCT of the kidney. The blood pressure, potassium, renin and aldosterone remained within the normal range after surgery. JCT of the kidney should be kept in mind because they represent a surgically curable cause of secondary hypertension. Nephron-sparing surgery is recommended.

Entities:  

Mesh:

Year:  2010        PMID: 20051908     DOI: 10.1097/HJH.0b013e328333b056

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  3 in total

1.  Reninoma coexisting with adrenal adenoma during pregnancy: A case report.

Authors:  Mei Xue; Yan Chen; Jin Zhang; Youyan Guan; Lin Yang; Bing Wu
Journal:  Oncol Lett       Date:  2017-03-03       Impact factor: 2.967

2.  A Rare Cause of Secondary Hypertension in A Young Adult.

Authors:  Jae-Hyuk Choi; Tae-Ho Park; Moo-Hyun Kim; Young-Dae Kim; Hyo In Rhyou; Seo Hee Rha; Kwon Jae Park; Jong Soo Woo
Journal:  Korean Circ J       Date:  2015-11-25       Impact factor: 3.243

Review 3.  Review of juxtaglomerular cell tumor with focus on pathobiological aspect.

Authors:  Naoto Kuroda; Hiroko Gotoda; Chisato Ohe; Shuji Mikami; Keiji Inoue; Yoji Nagashima; Fredrik Petersson; Isabel Alvarado-Cabrero; Chin-Chen Pan; Ondrej Hes; Michal Michal; Zoran Gatalica
Journal:  Diagn Pathol       Date:  2011-08-26       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.